advertisement

Topcon

Shimazawa M 1

Showing records 1 to 1 | Display all abstracts from Shimazawa M

11430 Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: Effects on ocular circulation and retinal neuronal damage
Hara H; Toriu N; Shimazawa M
Cardiovascular Drug Reviews 2004; 22: 199-214

Issue 6-3

Change Issue


advertisement

Topcon